Clinical Images: A snapshot from the past: untreated ankylosing spondylitis in the biologic era.
作者信息
Ciaffi Jacopo, Facchini Giancarlo, Bandiera Stefano, Cavallari Carlotta, Miceli Marco, Gasbarrini Alessandro, Ursini Francesco
机构信息
IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
出版信息
ACR Open Rheumatol. 2023 Jan;5(1):15-16. doi: 10.1002/acr2.11492. Epub 2022 Nov 29.
Abstract
摘要
相似文献
1
Clinical Images: A snapshot from the past: untreated ankylosing spondylitis in the biologic era.
ACR Open Rheumatol. 2023 Jan;5(1):15-16. doi: 10.1002/acr2.11492. Epub 2022 Nov 29.
2
Real-world experience of secukinumab treatment for ankylosing spondylitis at the Royal National Hospital for Rheumatic Diseases, Bath.
Clin Rheumatol. 2020 May;39(5):1501-1504. doi: 10.1007/s10067-020-04944-5. Epub 2020 Jan 27.
3
Recent advances in the treatment of the spondyloarthropathies.
Curr Opin Rheumatol. 2004 Jul;16(4):357-65. doi: 10.1097/01.bor.0000129719.21563.35.
4
Favorable effect of rehabilitation on balance in ankylosing spondylitis: a quasi-randomized controlled clinical trial.
Rheumatol Int. 2016 Mar;36(3):333-9. doi: 10.1007/s00296-015-3399-6. Epub 2015 Dec 7.
5
Cost-effectiveness analysis of secukinumab in ankylosing spondylitis from the Canadian perspective.
J Med Econ. 2019 Jan;22(1):45-52. doi: 10.1080/13696998.2018.1539400. Epub 2018 Nov 13.
6
Pharmacologic treatment of psoriatic arthritis and axial spondyloarthritis with traditional biologic and non-biologic DMARDs.
Best Pract Res Clin Rheumatol. 2014 Oct;28(5):793-806. doi: 10.1016/j.berh.2014.10.011. Epub 2014 Nov 22.
7
[The role of biologic agents in the therapy of ankylosing spondylitis].
Orv Hetil. 2006 Jul 2;147(26):1203-13.
8
Serum Vascular Endothelial Growth Factor Levels Lack Predictive Value in Patients with Active Ankylosing Spondylitis Treated with Golimumab.
J Rheumatol. 2016 May;43(5):901-6. doi: 10.3899/jrheum.150897. Epub 2016 Mar 1.
9
Serum biomarkers and changes in clinical/MRI evidence of golimumab-treated patients with ankylosing spondylitis: results of the randomized, placebo-controlled GO-RAISE study.
Arthritis Res Ther. 2016 Dec 28;18(1):304. doi: 10.1186/s13075-016-1200-1.
10
Benefit of Biological Drugs for Quality of Life in Patients with Ankylosing Spondylitis: A Systematic Review and Meta-Analysis of Clinical Trials.
Adv Exp Med Biol. 2021;1335:63-78. doi: 10.1007/5584_2020_611.
引用本文的文献
1
The Genetic Background of Ankylosing Spondylitis Reveals a Distinct Overlap with Autoimmune Diseases: A Systematic Review.
J Clin Med. 2025 May 23;14(11):3677. doi: 10.3390/jcm14113677.
本文引用的文献
1
Tumour necrosis factor inhibitors slow radiographic progression in patients with ankylosing spondylitis: 18-year real-world evidence.
Ann Rheum Dis. 2020 Oct;79(10):1327-1332. doi: 10.1136/annrheumdis-2019-216741. Epub 2020 Jul 13.
2
Biologic therapy and spinal radiographic progression in patients with axial spondyloarthritis: A structured literature review.
Ther Adv Musculoskelet Dis. 2020 Mar 4;12:1759720X20906040. doi: 10.1177/1759720X20906040. eCollection 2020.
3
Spinal fractures in patients with ankylosing spinal disorders: a systematic review of the literature on treatment, neurological status and complications.
Eur Spine J. 2009 Feb;18(2):145-56. doi: 10.1007/s00586-008-0764-0. Epub 2008 Sep 13.
Zotero 插件